3SBio Inc (83B) - Net Assets
Based on the latest financial reports, 3SBio Inc (83B) has net assets worth €30.44 Billion EUR (≈ $35.58 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€36.25 Billion ≈ $42.38 Billion USD) and total liabilities (€5.81 Billion ≈ $6.80 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 3SBio Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €30.44 Billion |
| % of Total Assets | 83.96% |
| Annual Growth Rate | 18.19% |
| 5-Year Change | 107.64% |
| 10-Year Change | N/A |
| Growth Volatility | 18.43 |
3SBio Inc - Net Assets Trend (2016–2025)
This chart illustrates how 3SBio Inc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of 3SBio Inc to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for 3SBio Inc (2016–2025)
The table below shows the annual net assets of 3SBio Inc from 2016 to 2025. For live valuation and market cap data, see 3SBio Inc stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €30.44 Billion ≈ $35.58 Billion |
+68.75% |
| 2024-12-31 | €18.04 Billion ≈ $21.09 Billion |
+9.22% |
| 2023-12-31 | €16.51 Billion ≈ $19.31 Billion |
+7.23% |
| 2022-12-31 | €15.40 Billion ≈ $18.00 Billion |
+5.07% |
| 2021-12-31 | €14.66 Billion ≈ $17.14 Billion |
+11.95% |
| 2020-12-31 | €13.09 Billion ≈ $15.31 Billion |
+26.39% |
| 2019-12-31 | €10.36 Billion ≈ $12.11 Billion |
+16.30% |
| 2018-12-31 | €8.91 Billion ≈ $10.41 Billion |
+16.75% |
| 2017-12-31 | €7.63 Billion ≈ $8.92 Billion |
+12.76% |
| 2016-12-31 | €6.77 Billion ≈ $7.91 Billion |
-- |
Equity Component Analysis
This analysis shows how different components contribute to 3SBio Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 908.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €18.31 Billion | 67.29% |
| Other Components | €8.90 Billion | 32.71% |
| Total Equity | €27.21 Billion | 100.00% |
3SBio Inc Competitors by Market Cap
The table below lists competitors of 3SBio Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
United Plantations Bhd
KLSE:2089
|
$5.15 Billion |
|
Zalando SE
XETRA:ZAL
|
$5.15 Billion |
|
Bank of Ayudhya Public Company Limited
F:NVAU
|
$5.15 Billion |
|
Westports Holdings Bhd
KLSE:5246
|
$5.16 Billion |
|
Turkcell Iletisim Hizmetleri A.S
F:TUL1
|
$5.15 Billion |
|
Jiangsu Jiejie Microelectronics Co Ltd
SHE:300623
|
$5.14 Billion |
|
CCC Intelligent Solutions Holdings Inc. Common Stock
NASDAQ:CCCS
|
$5.14 Billion |
|
China Great Wall Securities Co Ltd Class A
SHE:002939
|
$5.14 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in 3SBio Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 15,436,258,000 to 27,208,070,000, a change of 11,771,812,000 (76.3%).
- Net income of 8,482,164,000 contributed positively to equity growth.
- Dividend payments of 559,822,000 reduced retained earnings.
- New share issuances of 3,918,640,000 increased equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €8.48 Billion | +31.18% |
| Dividends Paid | €559.82 Million | -2.06% |
| Share Issuances | €3.92 Billion | +14.4% |
| Other Changes | €-69.17 Million | -0.25% |
| Total Change | €- | 76.26% |
Book Value vs Market Value Analysis
This analysis compares 3SBio Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.16x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.60x to 0.16x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €2.91 | €1.76 | x |
| 2018-12-31 | €3.39 | €1.76 | x |
| 2019-12-31 | €3.79 | €1.76 | x |
| 2020-12-31 | €4.20 | €1.76 | x |
| 2021-12-31 | €4.85 | €1.76 | x |
| 2022-12-31 | €5.32 | €1.76 | x |
| 2023-12-31 | €5.85 | €1.76 | x |
| 2024-12-31 | €6.55 | €1.76 | x |
| 2025-12-31 | €10.88 | €1.76 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently 3SBio Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 31.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 47.93%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.33x
- Recent ROE (31.18%) is above the historical average (14.04%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 10.92% | 25.47% | 0.25x | 1.69x | €60.31 Million |
| 2017 | 12.65% | 25.05% | 0.27x | 1.86x | €195.71 Million |
| 2018 | 14.83% | 27.86% | 0.33x | 1.61x | €415.72 Million |
| 2019 | 10.12% | 18.31% | 0.36x | 1.54x | €11.21 Million |
| 2020 | 7.82% | 14.96% | 0.32x | 1.65x | €-233.14 Million |
| 2021 | 13.50% | 25.87% | 0.33x | 1.57x | €428.50 Million |
| 2022 | 14.77% | 27.92% | 0.31x | 1.70x | €618.62 Million |
| 2023 | 11.04% | 19.82% | 0.33x | 1.68x | €145.86 Million |
| 2024 | 13.54% | 22.95% | 0.38x | 1.57x | €546.69 Million |
| 2025 | 31.18% | 47.93% | 0.49x | 1.33x | €5.76 Billion |
Industry Comparison
This section compares 3SBio Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $148,680,737
- Average return on equity (ROE) among peers: -34.42%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| 3SBio Inc (83B) | €30.44 Billion | 10.92% | 0.19x | $5.15 Billion |
| PROQR THERAPEUTICS EO-04 (0PQ) | $41.39 Million | -67.94% | 2.33x | $142.34 Million |
| TIZIANA LIFE SCIENCES LTD (0RP) | $41.28 Million | -56.73% | 0.18x | $145.06 Million |
| Theravance Biopharma Inc (0TB) | $-223.84 Million | 0.00% | 0.00x | $828.57 Million |
| I-MAB SPONS.ADS/1 -0001 (0VY) | $230.94 Million | -20.03% | 0.13x | $177.12 Million |
| PreveCeutical Medical Inc (18H) | $-6.64 Million | 0.00% | 0.00x | $3.34 Million |
| Argen-X (1AE) | $538.39 Million | -12.38% | 0.07x | $41.67 Billion |
| WAVE LIFE SCIENCES LTD. (1U5) | $39.63 Million | -145.12% | 5.94x | $1.14 Billion |
| BIOCURE TECHNOLOGY INC. (1WH) | $-2.33 Million | 0.00% | 0.00x | $960.84K |
| ZAI LAB LTD0000006 (1ZLB) | $796.12 Million | -42.03% | 0.30x | $1.82 Billion |
| BioNTech SE (22UA) | $31.86 Million | 0.00% | 11.24x | $20.05 Billion |
About 3SBio Inc
3SBio Inc., an investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People's Republic of China, the United States, and internationally. The company offers TPIAO bio-pharmaceutical drug for the treatment of chemotherapy-induced thrombocytopenia, immune thrombocytopenia, pediatric ITP, and chronic liver disease-related thromboc… Read more